| Value | ₹5,710 Cr |
|---|
BSE filing, NSE: POLICYBZR. Summary written from the filing by ALFA Finder's alert engine.
PB Fintech Ltd: key numbers
- Share price
- ₹1,000.10
- Market cap
- ₹46,280 Cr
- Revenue (annual)
- ₹6,794 Cr
- Net profit (annual)
- ₹669.9 Cr
- P/E (TTM)
- 61.9×Sector 23.5×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 27.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PB Fintech Ltd
All →PB Fintech Earnings Call Transcript: Key Takeaways
Management remains defiant despite draft IRDAI regulations potentially cutting distribution payouts, pivoting to 'pay for outcomes' and non-insurance revenue to sustain 30%+ core growth.
PB Fintech Financial Results
PB Fintech's board approved unaudited Q2 and H1 FY27 results on 30 October 2026, with PAT up 43% YoY to ₹192 Cr. The filing also encloses an earnings release and press release on insurance premium growth.
PB Fintech Capital Structure Change
HDFC Mutual Fund schemes raised their PB Fintech stake by 2.02% to 7.03% via open-market purchases. The acquisition was dated 28 October 2026.
PB Fintech Board Meeting Date
PB Fintech will hold a board meeting on 30 October 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed until 1 November 2026.
PB Fintech Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
PB Fintech Capital Structure Change
ICICI Prudential Mutual Fund bought 1,50,487 PB Fintech shares in open market on 16 Oct 2026, crossing 5%. The non-promoter stake crossing triggers this SAST Reg 29(1) disclosure.
Other fund raise announcements
All →Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.
Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr